Filing metadata

Accession number
0001493152-22-020883
Form type
Form 3
Filer
BriaCell Therapeutics Corp.
CIK
CIK 1610820
Filed
Aug 01, 2022
Reporting period
Aug 01, 2022
Description
Initial ownership

Explore SEC Filings Hub